Abstract
Background: Individuals with chronic diseases have persistent pain as the main symptom, which can often reduce their life quality and functional capacity. The suffering of patients results from the interaction of aversive perception of pain with physical disability, social and family isolation, financial worries and fear of mutilation and death. As an individual and subjective phenomenon that involves many complex aspects, chronic pain should be evaluated and treated in its various components. Several drugs are currently used, but besides the high cost, they have side effects that are harmful to patients. Therefore, there is the need to search for new options for pain relief. Natural products as monoterpenes have been the target of many researchers.
Objective: This systematic review aimed to briefly summarize the knowledge of the analgesic potential of monoterpenes facing chronic pain.
Results: After a search in PubMed, Lilacs, Scopus and Cochrane, 27 articles were selected, which described the analgesic potential of 16 monoterpenes for relief of chronic pain.
Conclusion: After analyzing the data, it can be suggested that these compounds are strong candidates for the treatment of painful states.
Keywords: Natural products, monoterpene, analgesic potential, chronic pain, chronic diseases, review.
Current Drug Targets
Title:Monoterpenes as Perspective to Chronic Pain Management: A Systematic Review
Volume: 19 Issue: 8
Author(s): Daniele Nascimento Gouveia, Lícia Tairiny Santos Pina, Thallita Kelly Rabelo, Wagner Barbosa da Rocha Santos, Jullyana Souza Siqueira Quintans and Adriana Gibara Guimaraes*
Affiliation:
- Department of Health Education, Federal University of Sergipe, Lagarto, Sergipe,Brazil
Keywords: Natural products, monoterpene, analgesic potential, chronic pain, chronic diseases, review.
Abstract: Background: Individuals with chronic diseases have persistent pain as the main symptom, which can often reduce their life quality and functional capacity. The suffering of patients results from the interaction of aversive perception of pain with physical disability, social and family isolation, financial worries and fear of mutilation and death. As an individual and subjective phenomenon that involves many complex aspects, chronic pain should be evaluated and treated in its various components. Several drugs are currently used, but besides the high cost, they have side effects that are harmful to patients. Therefore, there is the need to search for new options for pain relief. Natural products as monoterpenes have been the target of many researchers.
Objective: This systematic review aimed to briefly summarize the knowledge of the analgesic potential of monoterpenes facing chronic pain.
Results: After a search in PubMed, Lilacs, Scopus and Cochrane, 27 articles were selected, which described the analgesic potential of 16 monoterpenes for relief of chronic pain.
Conclusion: After analyzing the data, it can be suggested that these compounds are strong candidates for the treatment of painful states.
Export Options
About this article
Cite this article as:
Gouveia Nascimento Daniele, Pina Tairiny Santos Lícia , Rabelo Kelly Thallita , da Rocha Santos Barbosa Wagner, Quintans Souza Siqueira Jullyana and Guimaraes Gibara Adriana*, Monoterpenes as Perspective to Chronic Pain Management: A Systematic Review, Current Drug Targets 2018; 19 (8) . https://dx.doi.org/10.2174/1389450118666170711145308
DOI https://dx.doi.org/10.2174/1389450118666170711145308 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |
Call for Papers in Thematic Issues
New drug therapy for eye diseases
Eyesight is one of the most critical senses, accounting for over 80% of our perceptions. Our quality of life might be significantly affected by eye disease, including glaucoma, diabetic retinopathy, dry eye, etc. Although the development of microinvasive ocular surgery reduces surgical complications and improves overall outcomes, medication therapy is ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Natures Lessons to Design an Effective, Rational and Selective Drug for Soft Tissue Sarcoma Treatment: The Ecteinascidins
Drug Design Reviews - Online (Discontinued) Development of Prodrugs for Enzyme-Mediated, Tumor-Selective Therapy
Current Medicinal Chemistry - Anti-Cancer Agents Towards Cure of CML: Why We Need to Know More About CML Stem Cells?
Current Stem Cell Research & Therapy Current Constructs and Targets in Clinical Development for Antibody- Based Cancer Therapy
Current Drug Targets Dynamic Contrast Enhanced Magnetic Resonance Imaging in Oncology:Theory, Data Acquisition,Analysis, and Examples
Current Medical Imaging Cholesterol: A Prelate in Cell Nucleus and its Serendipity
Current Molecular Medicine A179L, a New Viral Bcl2 Homolog Targeting Beclin 1 Autophagy Related Protein
Current Molecular Medicine Antagonists of Growth Hormone-Releasing Hormone in Oncology
Combinatorial Chemistry & High Throughput Screening The c-Met Inhibitors: A New Class of Drugs in the Battle Against Advanced Nonsmall- Cell Lung Cancer
Current Pharmaceutical Design The Emerging Role of Vascular Endothelial Growth Factor (VEGF) in Vascular Homeostasis: Lessons from Recent Trials with Anti-VEGF Drugs
Current Vascular Pharmacology MDM2 Splice Variants and Their Therapeutic Implications
Current Cancer Drug Targets Proteases and their Receptors as Mediators of Inflammation-Associated Colon Cancer
Current Pharmaceutical Design Non-viral Delivery Systems for the Application in p53 Cancer Gene Therapy
Current Medicinal Chemistry Editorial [Hot Topic:Therapeutic Potential of Peptide Motifs - Part V (Executive Guest Editor: Jean-Claude Herve)]
Current Pharmaceutical Design Thiosemicarbazones as Potent Anticancer Agents and their Modes of Action
Mini-Reviews in Medicinal Chemistry Radioprotective Gene Therapy
Current Gene Therapy Immune Modulation of Asian Folk Herbal Medicines and Related Chemical Components for Cancer Management
Current Medicinal Chemistry NCRNA Combined Therapy as Future Treatment Option for Cancer
Current Pharmaceutical Design The Immunomodulatory Potential of Selected Bioactive Plant-Based Compounds in Breast Cancer: A Review
Anti-Cancer Agents in Medicinal Chemistry The Antagonists of Endothelin Receptors: Results and Perspectives
Current Pharmaceutical Analysis